Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

Details for Australian Patent Application No. 2008303023 (hide)

Owner Immunovaccine Technologies Inc.

Inventors Weir, Genevieve Mary; Mansour, Marc; Karkada, Mohan

Agent Spruson & Ferguson

Pub. Number AU-A-2008303023

PCT Pub. Number WO2009/039628

Priority 61/061,303 13.06.08 US; 60/975,602 27.09.07 US

Filing date 24 September 2008

Wipo publication date 2 April 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/88 (2006.01) Mutation or genetic engineering

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/039628 Priority application(s): WO2009/039628

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303027-Container for dispensing liquid doses

2008303007-Protocol for characterizing rock, method for characterizing rock hardness and methods for use therewith